prompt stringclasses 1
value | id stringlengths 11 11 | instruction stringlengths 710 15.1k | output stringlengths 47 105 | Train int64 0 0 |
|---|---|---|---|---|
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03874884 | {'Official Title': '177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer', 'Brief Summary': 'This phase 1 dose-escalation and dose-expansion study is designed to evaluate the safety and tolerability of olaparib in combination with 177Lutetium-Prostate Specific Membrane An... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03635567 | {'Official Title': 'A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Chemotherapy Plus Placebo for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer (KEYNOTE-826)', 'Brief Summary': 'The purpose of this study is to assess the... | {'Arm - Disease - Stage of Cancer': 'Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03635567 | {'Official Title': 'A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Chemotherapy Plus Placebo for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer (KEYNOTE-826)', 'Brief Summary': 'The purpose of this study is to assess the... | {'Arm - Disease - Stage of Cancer': 'Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03907488 | {'Official Title': 'A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma', 'Brief Summary': "This phase III trial compares immunotherapy drugs (nivolumab or brentuximab ved... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed, Stage III, Stage IV, Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03907488 | {'Official Title': 'A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma', 'Brief Summary': "This phase III trial compares immunotherapy drugs (nivolumab or brentuximab ved... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed, Stage III, Stage IV, Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03936270 | {'Official Title': 'Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer.', 'Brief Summary': 'The primary objective of this study is to evaluate 12 weeks progression-free survival (PFS) rate of Palbociclib plus Letrozole in ER/PR positive endome... | {'Arm - Disease - Stage of Cancer': 'High-Grade, Metastatic, Locoregional, Locally Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03627728 | {'Official Title': 'Phase II Randomized Study of Maintenance Regorafenib vs Placebo in no Progression Patients After First-line Platinum and Fluoropyrimidines Based Chemotherapy in HER2 Negative Locally Advanced/Metastatic Gastric or Gastroesophagel Junction Cancer (a-MANTRA Study)', 'Brief Summary': 'Randomized, doubl... | {'Arm - Disease - Stage of Cancer': 'Locally advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03627728 | {'Official Title': 'Phase II Randomized Study of Maintenance Regorafenib vs Placebo in no Progression Patients After First-line Platinum and Fluoropyrimidines Based Chemotherapy in HER2 Negative Locally Advanced/Metastatic Gastric or Gastroesophagel Junction Cancer (a-MANTRA Study)', 'Brief Summary': 'Randomized, doubl... | {'Arm - Disease - Stage of Cancer': 'Locally advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04590599 | {'Official Title': 'A Randomized, Double-blind, Controlled, Parallel-cohort Phase II Clinical Study to Assess the Efficacy and Safety of IBI310 or Placebo Combined With Sintilimab for Advanced Cervical Cancer Subjects Who Have Failed or Cannot Tolerate First-line or Above Platinum-based Chemotherapy', 'Brief Summary': ... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04590599 | {'Official Title': 'A Randomized, Double-blind, Controlled, Parallel-cohort Phase II Clinical Study to Assess the Efficacy and Safety of IBI310 or Placebo Combined With Sintilimab for Advanced Cervical Cancer Subjects Who Have Failed or Cannot Tolerate First-line or Above Platinum-based Chemotherapy', 'Brief Summary': ... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05608785 | {'Official Title': 'Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes', 'Brief Summary': 'Abstract Study title: Single-center, Multi-cohort Explorato... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05608785 | {'Official Title': 'Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes', 'Brief Summary': 'Abstract Study title: Single-center, Multi-cohort Explorato... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05608785 | {'Official Title': 'Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes', 'Brief Summary': 'Abstract Study title: Single-center, Multi-cohort Explorato... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05715840 | {'Official Title': 'A Randomised, Double-blind, Placebo-controlled, Multicentre Phase Ш Clinical Study to Evaluate the Efficacy and Safety of First-line Treatment With SG001 Plus Chemotherapy±Bevacizumab Versus Placebo Plus Chemotherapy±Bevacizumab for PD-L1 Positive (CPS≥1) Women With Recurrent, or Metastatic Cervical... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05715840 | {'Official Title': 'A Randomised, Double-blind, Placebo-controlled, Multicentre Phase Ш Clinical Study to Evaluate the Efficacy and Safety of First-line Treatment With SG001 Plus Chemotherapy±Bevacizumab Versus Placebo Plus Chemotherapy±Bevacizumab for PD-L1 Positive (CPS≥1) Women With Recurrent, or Metastatic Cervical... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05529667 | {'Official Title': 'An Open Label, Single-Arm, Multi-center Phase Ib/II Study to Evaluate the Safety and Efficacy of INCB054828 in Combination With Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer With FGFs/FGFRs Genetic Aberration.', 'Brief Summary': 'This study was conducted as a second-line... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04269200 | {'Official Title': 'A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination With Durvalumab, Followed by Maintenance Durvalumab With or Without Olaparib in Patients With Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)', 'Brief... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed, Advanced, Stage III, Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04269200 | {'Official Title': 'A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination With Durvalumab, Followed by Maintenance Durvalumab With or Without Olaparib in Patients With Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)', 'Brief... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed, Advanced, Stage III, Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04269200 | {'Official Title': 'A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination With Durvalumab, Followed by Maintenance Durvalumab With or Without Olaparib in Patients With Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)', 'Brief... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed, Advanced, Stage III, Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03617679 | {'Official Title': 'A Phase II, Randomized, Double-Blind Study of the Use of Rucaparib vs. Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer', 'Brief Summary': 'This study seeks to determine the effectiveness of Rucaparib as maintenance therapy for metastatic and recurrent endometrial cancer, a... | {'Arm - Disease - Stage of Cancer': 'Stage III, Stage IV, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03617679 | {'Official Title': 'A Phase II, Randomized, Double-Blind Study of the Use of Rucaparib vs. Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer', 'Brief Summary': 'This study seeks to determine the effectiveness of Rucaparib as maintenance therapy for metastatic and recurrent endometrial cancer, a... | {'Arm - Disease - Stage of Cancer': 'Stage III, Stage IV, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05422911 | {'Official Title': 'A Phase 2 Randomized Study of YONSA® (Abiraterone Acetate), Enzalutamide or Apalutamide as First Line Therapy in Veterans With Castrate-sensitive Prostate Cancer', 'Brief Summary': 'The investigators have used national VHA data to demonstrate real-world efficacy of abiraterone and enzalutamide in Ve... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05422911 | {'Official Title': 'A Phase 2 Randomized Study of YONSA® (Abiraterone Acetate), Enzalutamide or Apalutamide as First Line Therapy in Veterans With Castrate-sensitive Prostate Cancer', 'Brief Summary': 'The investigators have used national VHA data to demonstrate real-world efficacy of abiraterone and enzalutamide in Ve... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04934722 | {'Official Title': 'A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (KEYNOTE-991)', 'Brief Summary': 'This study will assess the efficacy and safety of pemb... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04934722 | {'Official Title': 'A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (KEYNOTE-991)', 'Brief Summary': 'This study will assess the efficacy and safety of pemb... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05201352 | {'Official Title': 'Multicentric Randomized Phase I/II Study to Evaluate Efficacy of Trifluridine/Tipiracil Plus XB2001 (Anti-IL-1α True Human Antibody) Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine', 'Brief Summary': 'Unre... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05201352 | {'Official Title': 'Multicentric Randomized Phase I/II Study to Evaluate Efficacy of Trifluridine/Tipiracil Plus XB2001 (Anti-IL-1α True Human Antibody) Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine', 'Brief Summary': 'Unre... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03875235 | {'Official Title': 'A Phase III Randomized, Double-Blind Placebo Controlled, Multi-Regional, International Study of Durvalumab in Combination With Gemcitabine Plus Cisplatin Versus Placebo in Combination With Gemcitabine Plus Cisplatin for Patients With First-Line Advanced Biliary Tract Cancers', 'Brief Summary': 'Durv... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03875235 | {'Official Title': 'A Phase III Randomized, Double-Blind Placebo Controlled, Multi-Regional, International Study of Durvalumab in Combination With Gemcitabine Plus Cisplatin Versus Placebo in Combination With Gemcitabine Plus Cisplatin for Patients With First-Line Advanced Biliary Tract Cancers', 'Brief Summary': 'Durv... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT01972217 | {'Official Title': 'A Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Study to Compare the Efficacy, Safety and Tolerability of Olaparib Versus Placebo When Given in Addition to Abiraterone Treatment in Patients With Metastatic Castrate-Resistant Prostate Cancer Who Have Received Prior Chemotherapy C... | {'Arm - Disease - Stage of Cancer': 'Metastatic '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT01972217 | {'Official Title': 'A Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Study to Compare the Efficacy, Safety and Tolerability of Olaparib Versus Placebo When Given in Addition to Abiraterone Treatment in Patients With Metastatic Castrate-Resistant Prostate Cancer Who Have Received Prior Chemotherapy C... | {'Arm - Disease - Stage of Cancer': 'Metastatic '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05797831 | {'Official Title': 'A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects With TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy', 'Brief Summary': 'This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who hav... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05797831 | {'Official Title': 'A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects With TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy', 'Brief Summary': 'This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who hav... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05797831 | {'Official Title': 'A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects With TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy', 'Brief Summary': 'This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who hav... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05797831 | {'Official Title': 'A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects With TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy', 'Brief Summary': 'This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who hav... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05797831 | {'Official Title': 'A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects With TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy', 'Brief Summary': 'This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who hav... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05797831 | {'Official Title': 'A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects With TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy', 'Brief Summary': 'This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who hav... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05797831 | {'Official Title': 'A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects With TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy', 'Brief Summary': 'This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who hav... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04634877 | {'Official Title': 'A Phase 3, Randomized, Double-Blind Study of Pembrolizumab Versus Placebo in Combination With Adjuvant Chemotherapy With or Without Radiotherapy for the Treatment of Newly Diagnosed High-Risk Endometrial Cancer After Surgery With Curative Intent (KEYNOTE-B21 / ENGOT-en11 / GOG-3053)', 'Brief Summary... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed,'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04634877 | {'Official Title': 'A Phase 3, Randomized, Double-Blind Study of Pembrolizumab Versus Placebo in Combination With Adjuvant Chemotherapy With or Without Radiotherapy for the Treatment of Newly Diagnosed High-Risk Endometrial Cancer After Surgery With Curative Intent (KEYNOTE-B21 / ENGOT-en11 / GOG-3053)', 'Brief Summary... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02043678 | {'Official Title': 'A Phase III Randomized, Double-blind, Placebo-controlled Trial of Radium-223 Dichloride in Combination With Abiraterone Acetate and Prednisone/Prednisolone in the Treatment of Asymptomatic or Mildly Symptomatic Chemotherapy-naïve Subjects With Bone Predominant Metastatic Castration-resistant Prostat... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02043678 | {'Official Title': 'A Phase III Randomized, Double-blind, Placebo-controlled Trial of Radium-223 Dichloride in Combination With Abiraterone Acetate and Prednisone/Prednisolone in the Treatment of Asymptomatic or Mildly Symptomatic Chemotherapy-naïve Subjects With Bone Predominant Metastatic Castration-resistant Prostat... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT01068249 | {'Official Title': 'A Phase II Study of Letrozole and RAD001 (Everolimus) in Patients With Advanced or Recurrent Endometrial Cancer', 'Brief Summary': 'The goal of this clinical research study is to learn if the combination of RAD001 (everolimus) and Femara (letrozole) can help to control recurrent or progressive endom... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05260671 | {'Official Title': 'An Exploratory Clinical Study to Evaluate the Efficacy and Safety of Penpulimab in Combination With Cetuximab as First-line Treatment in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/MSCCHN)', 'Brief Summary': 'This trial is a multicenter, prospective, single-arm... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03400332 | {'Official Title': 'A Phase 1/2 Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers', 'Brief Summary': 'The purpose of this study is to investigate experimental medication BMS-986253 in combination with Nivolumab or Nivolumab plus Ipilimumab in participants with advanced c... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03400332 | {'Official Title': 'A Phase 1/2 Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers', 'Brief Summary': 'The purpose of this study is to investigate experimental medication BMS-986253 in combination with Nivolumab or Nivolumab plus Ipilimumab in participants with advanced c... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03400332 | {'Official Title': 'A Phase 1/2 Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers', 'Brief Summary': 'The purpose of this study is to investigate experimental medication BMS-986253 in combination with Nivolumab or Nivolumab plus Ipilimumab in participants with advanced c... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03400332 | {'Official Title': 'A Phase 1/2 Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers', 'Brief Summary': 'The purpose of this study is to investigate experimental medication BMS-986253 in combination with Nivolumab or Nivolumab plus Ipilimumab in participants with advanced c... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03400332 | {'Official Title': 'A Phase 1/2 Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers', 'Brief Summary': 'The purpose of this study is to investigate experimental medication BMS-986253 in combination with Nivolumab or Nivolumab plus Ipilimumab in participants with advanced c... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03924869 | {'Official Title': 'A Phase 3, Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Participants With Unresected Stages I or II Non Small Cell Lung Cancer (NSCLC) (KEYNOTE-867)', 'Brief Summary': 'The purpos... | {'Arm - Disease - Stage of Cancer': 'Stage I, Stage II '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03924869 | {'Official Title': 'A Phase 3, Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Participants With Unresected Stages I or II Non Small Cell Lung Cancer (NSCLC) (KEYNOTE-867)', 'Brief Summary': 'The purpos... | {'Arm - Disease - Stage of Cancer': 'Stage I, Stage II '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02667587 | {'Official Title': 'A Randomized Phase 3 Single Blind Study of Temozolomide Plus Radiation Therapy Combined With Nivolumab or Placebo in Newly Diagnosed Adult Subjects With MGMT-Methylated (Tumor O6-methylguanine DNA Methyltransferase) Glioblastoma', 'Brief Summary': 'The purpose of this study is to evaluate patients w... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02667587 | {'Official Title': 'A Randomized Phase 3 Single Blind Study of Temozolomide Plus Radiation Therapy Combined With Nivolumab or Placebo in Newly Diagnosed Adult Subjects With MGMT-Methylated (Tumor O6-methylguanine DNA Methyltransferase) Glioblastoma', 'Brief Summary': 'The purpose of this study is to evaluate patients w... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04982237 | {'Official Title': 'A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate AK104 Plus Platinum-containing Chemotherapy With or Without Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer', 'Brief Summary': 'This is A Randomized, Double-blind, Placebo-controll... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04982237 | {'Official Title': 'A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate AK104 Plus Platinum-containing Chemotherapy With or Without Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer', 'Brief Summary': 'This is A Randomized, Double-blind, Placebo-controll... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03631199 | {'Official Title': 'A Randomized, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab as First Line Therapy for Locally Advanced or Metastatic Non-squamous and Squamous Non-small Cell Lung Cancer Subje... | {'Arm - Disease - Stage of Cancer': 'Stage IIIB or Stage IV, Advanced or Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03631199 | {'Official Title': 'A Randomized, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab as First Line Therapy for Locally Advanced or Metastatic Non-squamous and Squamous Non-small Cell Lung Cancer Subje... | {'Arm - Disease - Stage of Cancer': 'Stage IIIB or Stage IV, Advanced or Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05052801 | {'Official Title': 'A Randomized, Multi-center, Double-blind, Placebo-controlled Phase 3 Study of Bemarituzumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer With FGFR2b Overexpression', 'Brief Summary': 'The main objective ... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05052801 | {'Official Title': 'A Randomized, Multi-center, Double-blind, Placebo-controlled Phase 3 Study of Bemarituzumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer With FGFR2b Overexpression', 'Brief Summary': 'The main objective ... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05029102 | {'Official Title': 'TAS-102 Combined With Anlotinib in Patients With Metastatic Gastric Cancer Refractory to Standard Treatments (THALIA): a Prospective Single-arm Phase II Study', 'Brief Summary': 'To determine the efficacy and safety of TAS-102 and Anlotinib in patients with metastatic gastric cancer who had been tre... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05481463 | {'Official Title': 'A Open-label, Single-arm, Single-center, Phase II Clinical Study of Surufatinib Combined With TAS-102 in Third-line and Later-line Therapy of Patients With Advanced Pancreatic Cancer', 'Brief Summary': 'This is a single-center, single-arm, open-label, phase 2 clinical study, to explore the efficacy ... | {'Arm - Disease - Stage of Cancer': 'Locally advanced or metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05672316 | {'Official Title': 'A Phase I/II Trial of Botensilimab, Balstilimab and Regorafenib (BBR) in Patients With Microsatellite Stable (MSS) Metastatic Colorectal Cancer Who Progressed on Prior Chemotherapy', 'Brief Summary': "This phase I/II trial tests how well botensilimab, balstilimab, and regorafenib works in treating p... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02257736 | {'Official Title': 'A Phase 3 Randomized, Placebo-controlled Double-blind Study of JNJ-56021927 in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Subjects With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)', 'Brief Summary': 'The purpose of ... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02257736 | {'Official Title': 'A Phase 3 Randomized, Placebo-controlled Double-blind Study of JNJ-56021927 in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Subjects With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)', 'Brief Summary': 'The purpose of ... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05353257 | {'Official Title': 'A Randomized, Double-Blind, International Multicenter, Phase III Study to Evaluate the Anti-Tumor Efficacy and Safety of Serplulimab or Placebo in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer', 'Brief Summary': 'This study is a rando... | {'Arm - Disease - Stage of Cancer': 'Limited Stage, Stage I, Stage II, Stage III'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05353257 | {'Official Title': 'A Randomized, Double-Blind, International Multicenter, Phase III Study to Evaluate the Anti-Tumor Efficacy and Safety of Serplulimab or Placebo in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer', 'Brief Summary': 'This study is a rando... | {'Arm - Disease - Stage of Cancer': 'Limited Stage, Stage I, Stage II, Stage III'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05328908 | {'Official Title': 'A Phase 3, Randomized, Open-label Study of Relatlimab-nivolumab Fixed-dose Combination Versus Regorafenib or Trifluridine + Tipiracil (TAS-102) for Participants With Later-lines of Metastatic Colorectal Cancer', 'Brief Summary': 'The purpose of this study is to evaluate relatlimab in combination wit... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05328908 | {'Official Title': 'A Phase 3, Randomized, Open-label Study of Relatlimab-nivolumab Fixed-dose Combination Versus Regorafenib or Trifluridine + Tipiracil (TAS-102) for Participants With Later-lines of Metastatic Colorectal Cancer', 'Brief Summary': 'The purpose of this study is to evaluate relatlimab in combination wit... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03959293 | {'Official Title': 'A Randomized Phase II Study Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma', 'Brief Summary': 'Gastric adenocarcinoma is the 4th most frequent cancer and the 2nd leading... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03959293 | {'Official Title': 'A Randomized Phase II Study Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma\n', 'Brief Summary': 'Gastric adenocarcinoma is the 4th most frequent cancer and the 2nd leadi... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03863483 | {'Official Title': 'A Phase II, Prospective, Single-center, Randomized, Controlled Study to Investigate the Efficacy and Safety of Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Plat... | {'Arm - Disease - Stage of Cancer': 'Stage IV '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03863483 | {'Official Title': 'A Phase II, Prospective, Single-center, Randomized, Controlled Study to Investigate the Efficacy and Safety of Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Plat... | {'Arm - Disease - Stage of Cancer': 'Stage IV '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05179239 | {'Official Title': 'A Randomized，Double-blind，Controlled，Multi-center Phase III Clinical Study Evaluating SHR-1701 or Placebo Plus Chemotherapy With or Without BP102 (Bevacizumab) as First-Line Treatment in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer', 'Brief Summary': 'The study is being conduct... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05179239 | {'Official Title': 'A Randomized，Double-blind，Controlled，Multi-center Phase III Clinical Study Evaluating SHR-1701 or Placebo Plus Chemotherapy With or Without BP102 (Bevacizumab) as First-Line Treatment in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer', 'Brief Summary': 'The study is being conduct... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05179239 | {'Official Title': 'A Randomized，Double-blind，Controlled，Multi-center Phase III Clinical Study Evaluating SHR-1701 or Placebo Plus Chemotherapy With or Without BP102 (Bevacizumab) as First-Line Treatment in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer', 'Brief Summary': 'The study is being conduct... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04732494 | {'Official Title': 'A Phase 2, Multicenter, Randomized, Placebo-Controlled Study to Compare the Efficacy of Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Plus Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) Versus Tislelizumab Plus Placebo as Second-Line Treatment in Patients With PD-L1 Tumor Area Positi... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04732494 | {'Official Title': 'A Phase 2, Multicenter, Randomized, Placebo-Controlled Study to Compare the Efficacy of Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Plus Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) Versus Tislelizumab Plus Placebo as Second-Line Treatment in Patients With PD-L1 Tumor Area Positi... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04269200 | {'Official Title': 'A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination With Durvalumab, Followed by Maintenance Durvalumab With or Without Olaparib in Patients With Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)\n', 'Bri... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04269200 | {'Official Title': 'A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination With Durvalumab, Followed by Maintenance Durvalumab With or Without Olaparib in Patients With Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)\n', 'Bri... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04269200 | {'Official Title': 'A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination With Durvalumab, Followed by Maintenance Durvalumab With or Without Olaparib in Patients With Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)\n', 'Bri... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04916613 | {'Official Title': 'A Double-blind Randomised Phase III Trial Evaluating the Efficacy of ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability and Not Elected for Docetaxel or Androgen Receptor Targeted Agents', 'Brief Summary': 'This is a Phase III, international, multi... | {'Arm - Disease - Stage of Cancer': 'Metastatic '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04916613 | {'Official Title': 'A Double-blind Randomised Phase III Trial Evaluating the Efficacy of ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability and Not Elected for Docetaxel or Androgen Receptor Targeted Agents', 'Brief Summary': 'This is a Phase III, international, multi... | {'Arm - Disease - Stage of Cancer': 'Metastatic '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03740165 | {'Official Title': 'A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First-Line Treatment of BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (KEYLYNK-001 / ENGOT-ov43 / GOG-3036)', 'Brief Summary': 'The purpose of t... | {'Arm - Disease - Stage of Cancer': 'Advanced Stage III or Stage IV EOC'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03740165 | {'Official Title': 'A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First-Line Treatment of BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (KEYLYNK-001 / ENGOT-ov43 / GOG-3036)', 'Brief Summary': 'The purpose of t... | {'Arm - Disease - Stage of Cancer': 'Advanced Stage III or Stage IV EOC'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03740165 | {'Official Title': 'A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First-Line Treatment of BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (KEYLYNK-001 / ENGOT-ov43 / GOG-3036)', 'Brief Summary': 'The purpose of t... | {'Arm - Disease - Stage of Cancer': 'Advanced Stage III or Stage IV EOC'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05580562 | {'Official Title': 'ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study', 'Brief Summary': 'This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study i... | {'Arm - Disease - Stage of Cancer': 'Newly diagnosed'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05580562 | {'Official Title': 'ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study', 'Brief Summary': 'This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study i... | {'Arm - Disease - Stage of Cancer': 'Newly diagnosed'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05580562 | {'Official Title': 'ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study', 'Brief Summary': 'This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study i... | {'Arm - Disease - Stage of Cancer': 'Newly diagnosed'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04853043 | {'Official Title': 'APK Mutant: A Single Arm Phase II Study of Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer', 'Brief Summary': 'A prospective, multi-center, phase II study of 21 patients to evaluate the efficacy of the EGFR inhibitor, Cetuximab in patients w... | {'Arm - Disease - Stage of Cancer': 'Metastatic '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05987358 | {'Official Title': 'A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of TQB3454 Tablets in the Treatment of Advanced Biliary Tract Cancer With Isocitrate Dehydrogenase 1 (IDH1) Mutation.\n', 'Brief Summary': 'This study used a randomized, controlled, double... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05987358 | {'Official Title': 'A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of TQB3454 Tablets in the Treatment of Advanced Biliary Tract Cancer With Isocitrate Dehydrogenase 1 (IDH1) Mutation.\n', 'Brief Summary': 'This study used a randomized, controlled, double... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02773524 | {'Official Title': 'A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)\n', 'Brief Summary': 'A randomised phase III, double-blind, placebo-controlled trial with 2:1 (regorafenib : placebo)\n', 'Condition': 'Gastro-Oesophageal Cancer\n', 'D... | {'Arm - Disease - Stage of Cancer': 'Metastatic/Locally Recurrent'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02773524 | {'Official Title': 'A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)\n', 'Brief Summary': 'A randomised phase III, double-blind, placebo-controlled trial with 2:1 (regorafenib : placebo)\n', 'Condition': 'Gastro-Oesophageal Cancer\n', 'D... | {'Arm - Disease - Stage of Cancer': 'Metastatic/Locally Recurrent'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05270044 | {'Official Title': 'Adjuvant Encorafenib & Binimetinib vs. Placebo in Fully Resected Stage IIB/C BRAF V600E/K Mutated Melanoma: a Randomized Triple-blind Phase III Study in Collaboration With the EORTC Melanoma Group', 'Brief Summary': 'The purpose of the Columbus-AD study is to evaluate the efficacy and safety of 12 m... | {'Arm - Disease - Stage of Cancer': 'Stage IIB/C '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05270044 | {'Official Title': 'Adjuvant Encorafenib & Binimetinib vs. Placebo in Fully Resected Stage IIB/C BRAF V600E/K Mutated Melanoma: a Randomized Triple-blind Phase III Study in Collaboration With the EORTC Melanoma Group', 'Brief Summary': 'The purpose of the Columbus-AD study is to evaluate the efficacy and safety of 12 m... | {'Arm - Disease - Stage of Cancer': 'Stage IIB/C '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03981614 | {'Official Title': 'Combination of MEK Inhibitor Binimetinib and CDK4/6 Inhibitor Palbociclib in KRAS and NRAS Mutant Metastatic Colorectal Cancers\n', 'Brief Summary': 'This phase II trial studies how well binimetinib and palbociclib work compared to TAS-102 in treating patients with KRAS and NRAS mutation positive co... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03981614 | {'Official Title': 'Combination of MEK Inhibitor Binimetinib and CDK4/6 Inhibitor Palbociclib in KRAS and NRAS Mutant Metastatic Colorectal Cancers\n', 'Brief Summary': 'This phase II trial studies how well binimetinib and palbociclib work compared to TAS-102 in treating patients with KRAS and NRAS mutation positive co... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05920356 | {'Official Title': 'A Phase 3, Multicenter, Randomized, Open-label Study Evaluating Efficacy of Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers, Negative for PD-L1,... | {'Arm - Disease - Stage of Cancer': 'Stage IV, Advanced Stage IIIB, Stage IIIIC'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05920356 | {'Official Title': 'A Phase 3, Multicenter, Randomized, Open-label Study Evaluating Efficacy of Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers, Negative for PD-L1,... | {'Arm - Disease - Stage of Cancer': 'Stage IV, Advanced Stage IIIB, Stage IIIIC'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02642042 | {'Official Title': 'A Phase II Trial of Trametinib With Docetaxel in Patients With KRAS Mutation Positive Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease Following One or Two Prior Systemic Therapies', 'Brief Summary': 'This phase II trial studies how well trametinib and docetaxel work in treating patients w... | {'Arm - Disease - Stage of Cancer': ' Stage IV'} | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.